Difference between revisions of "Xia W, et al. Oncotarget (2017) cited as Ref 346 in DOI: 10.1038/s41392-020-0110-5 (Q9609)"
Jump to navigation
Jump to search
(Created claim: title (P93): Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-beta/Smad-regulated liver cancer stem cell-like cells, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 38811-38824, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 38811-38824 | ||
| Property / Page(s): 38811-38824 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:38, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Xia W, et al. Oncotarget (2017) cited as Ref 346 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Xia W
0 references
2017
0 references
Oncotarget
0 references
8
0 references
Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-beta/Smad-regulated liver cancer stem cell-like cells (English)
0 references
38811-38824
0 references
